Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Ada

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Research in Virology|September 1, 1989
How do vaccinia-vectored vaccines fit into human immunization programmes?G L Ada
The Medical Journal of Australia|September 25, 1999
Frank Macfarlane Burnet: virologist, immunologist and Nobel Prize WinnerG L Ada
IARC Scientific Publications|January 1, 1982
Host factors important in immune surveillance against tumoursG L Ada
Annals of the Academy of Medicine, Singapore|April 1, 1988
Modern approaches to vaccine development with special reference to the needs of developing countriesG L Ada
Transplantation Reviews|January 1, 1970
Antigen binding cells in tolerance and immunityG L Ada
The Medical Journal of Australia|May 31, 2001
Exploring the unknown: the challenges of a career in biomedical researchG L Ada
Developments in Biological Standardization|January 1, 1994
Human vaccinesG L Ada
Scandinavian Journal of Immunology|July 1, 1985
Influenza virus-specific T cells fail to reduce lung virus titres in cyclosporin-treated, infected miceE Schiltknecht, G L Ada
Transplantation Proceedings|April 1, 1986
In vivo effects of cyclosporine in the generation and expression of effector cell functionE Schiltknecht, G L Ada
Nature Medicine|October 1, 1996
SIV and HIV prophylaxisG L Ada, A Müllbacher
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Research in Virology|September 1, 1989
How do vaccinia-vectored vaccines fit into human immunization programmes?G L Ada
The Medical Journal of Australia|September 25, 1999
Frank Macfarlane Burnet: virologist, immunologist and Nobel Prize WinnerG L Ada
IARC Scientific Publications|January 1, 1982
Host factors important in immune surveillance against tumoursG L Ada
Annals of the Academy of Medicine, Singapore|April 1, 1988
Modern approaches to vaccine development with special reference to the needs of developing countriesG L Ada
Transplantation Reviews|January 1, 1970
Antigen binding cells in tolerance and immunityG L Ada
The Medical Journal of Australia|May 31, 2001
Exploring the unknown: the challenges of a career in biomedical researchG L Ada
Developments in Biological Standardization|January 1, 1994
Human vaccinesG L Ada
Scandinavian Journal of Immunology|July 1, 1985
Influenza virus-specific T cells fail to reduce lung virus titres in cyclosporin-treated, infected miceE Schiltknecht, G L Ada
Transplantation Proceedings|April 1, 1986
In vivo effects of cyclosporine in the generation and expression of effector cell functionE Schiltknecht, G L Ada
Nature Medicine|October 1, 1996
SIV and HIV prophylaxisG L Ada, A Müllbacher
Pageof 9